Tuesday, 11 September 2012

Neptune Q2 Record Revenue Guidance – Beats Roth Estimates



Neptune Technologies & Bioressources
TSX: NTB - NASDAQ: NEPT
Basic Shares: 48.2 million
Fully diluted: 53.9 million
**************************

Neptune roared out of the trading gate this morning as the market opened with news that Neptune is calling for record 2nd quarter revenues. Management believes the company will do $7.5 million to $8 million, which represents an increase of 72% to 84% from the same quarter last year.

Roth Capital, with a $10.30 BUY target on Neptune, estimated Q2 would come in at $6.3 million. Click here to view Roth’s September 6, 2012 Flash Note on Neptune.

Neptune management attribute the “accelerated sales” to “the quality of Neptune’s krill oil products, aggressive sales strategy, greater consumer awareness and our strong patent portfolio…”

To view today’s news release please click here.